Liraglutide In Pakistan

Liraglutide In Pakistan - This medicine is used to control blood glucose levels in type 2 diabetics with a proper program of exercise and diet. It is also prescribed for patients with type 2 diabetes who are at risk of heart attack or stroke and who have some type of heart or blood vessel disease. Another common use of this drug is to help obese patients lose weight along with exercise and a low-calorie diet plan.

Mean age of cohort was 55 years (SD=10.94 years) with median body mass index of 36.45 kg/m2 and majority (57.35%) were on a dose of 1.2 mg of Liraglutide per day. Median HbA1c reduced to 7.50% and 7.40% at three months and six months respectively vs 8.45% at baseline. Mean reduction in weight after three months was two kilograms and at six months, it was 1.38 kilograms respectively.

Liraglutide side effects:

Some patients may experience gastrointestinal disturbances (stomach disorders), headache, dizziness, low blood glucose levels, toothache, anorexia, fatigue, fever, injection site reaction. If you experience any of these symptoms, see your doctor.

This retrospective study was conducted at the Endocrinology Clinics of Aga Khan University Hospital (AKUH) Karachi, Pakistan during the period from July 01, 2016 to 30th June, 2017. Liraglutide was prescribed to 68 obese type two diabetes patients with uncontrolled diabetes taking more than one oral medication ± insulin.

Liraglutide Uses:

Liraglutide is an antidiabetic drug used in the treatment of type 2 diabetes in adult patients. Patients are advised to follow a strict diet and exercise regimen along with this medication for the best possible effect. This medication is not recommended for use in patients with type 1 diabetes and diabetic ketoacidosis.
Background and objective: GLP-one receptor agonists are among the only antidiabetic drugs that have important metabolic and cardiovascular benefits in addition to the hypoglycemic effect. To the best of our knowledge, there are no published data on the efficacy of liraglutide use among the Pakistani population. Our objective was to determine the efficacy of liraglutide use in patients with type 2 diabetes.